Metformin enhances autophagy and inhibits abnormal cell proliferation through the AMPK/SIRT1-FoxO1 pathway, thereby mitigating oxidative stress in diabetic nephropathy (67). The gene discussed is FOXO1; the disease is diabetic kidney disease.